Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation

Molecular Medicine Reports

Volumn 13, Issue 1, 2016, Pages 13-20

  Zhao, Mingfei ^a   Liang, Feng ^a   Xu, Hangdi ^b   Yan, Wei ^a   Zhang, Jianmin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Autophagy; Methylene blue; Microglia; Traumatic brain injury

Indexed keywords

BECLIN 1; METHYLENE BLUE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BRAIN DAMAGE; BRAIN EDEMA; BRAIN SIZE; BRAIN WATER; BRAIN WATER CONTENT; CONTROLLED STUDY; HEMISPHERE; MALE; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; TRAUMATIC BRAIN INJURY; UPREGULATION; ANIMAL; BRAIN INJURIES; COMPLICATION; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; BRAIN EDEMA; BRAIN INJURIES; MALE; METHYLENE BLUE; MICE, INBRED ICR; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; TREATMENT OUTCOME;

EID: 84954243597     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4551     Document Type: Article

References (40)

1. Feigin VL, Theadom A, Barker-Collo S, Starkey NJ, McPherson K, Kahan M, Dowell A, Brown P, Parag V, Kydd R, et al; BIONIC Study Group: Incidence of traumatic brain injury in New Zealand: A population-based study. Lancet Neurol 12: 53-64, 2013.
2. Dvela-Levitt M, Ami HC, Rosen H, Shohami E and Lichtstein D: Ouabain improves functional recovery following traumatic brain injury. J Neurotrauma 31: 1942-1947, 2014
3. Fenn AM, Skendelas JP, Moussa DN, Muccigrosso MM, Popovich PG, Lifshitz J, Eiferman DS and Godbout JP: Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice. J Neurotrauma 32: 127-138, 2014.
4. Xiong Y, Mahmood A and Chopp M: Animal models of traumatic brain injury. Nat Rev Neurosci 14: 128-142, 2013.
5. Auchter A, Williams J, Barksdale B, Monfils MH and Gonzalez-Lima F: Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion. J Alzheimers Dis 42 Suppl 4: S525-S535, 2014.
6. Kwok ES and Howes D: Use of methylene blue in sepsis: A systematic review. J Intensive Care Med 21: 359-363, 2006.
7. Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J and Singh AK: The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg 103: 2-8, 2006.
8. Paciullo CA, McMahon Horner D, Hatton KW and Flynn JD: Methylene blue for the treatment of septic shock. Pharmacotherapy 30: 702-715, 2010.
9. Rojas JC, Bruchey AK and Gonzalez-Lima F: Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol 96: 32-45, 2012.
10. Dibaj P, Zschuntzsch J, Steffens H, Scheffel J, Goricke B, Weishaupt JH, Le Meur K, Kirchhoff F, Hanisch UK, Schomburg ED, et al: Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS. PLoS One 7: e43963, 2012.
11. Shen Q, Du F, Huang S, Rodriguez P, Watts LT and Duong TQ: Neuroprotective efficacy of methylene blue in ischemic stroke: An MRI study. PLoS One 8: e79833, 2013.
12. Talley Watts L, Long JA, Chemello J, Van Koughnet S, Fernandez A, Huang S, Shen Q and Duong TQ: Methylene blue is neuroprotective against mild traumatic brain injury. J Neurotrauma 31: 1063-1071, 2014.
13. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals. 8th edition. National Academies Press, Washington DC, 2011
14. Hong Y, Yan W, Chen S, Sun CR and Zhang JM: The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacol Sin 31: 1421-1430, 2010.
15. Callaway NL, Riha PD, Bruchey AK, Munshi Z and Gonzalez-Lima F: Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacol Biochem Behav 77: 175-181, 2004.
16. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J and Chopp M: Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32: 2682-2688, 2001.
17. Xu J, Wang H, Ding K, Lu X, Li T, Wang J, Wang C and Wang J: Inhibition of cathepsin S produces neuroprotective effects after traumatic brain injury in mice. Mediators Inflamm 2013: 187873, 2013.
18. Wang H, Liao Z, Sun X, Shi Q, Huo G, Xie Y, Tang X, Zhi X and Tang Z: Intravenous administration of Honokiol provides neuroprotection and improves functional recovery after traumatic brain injury through cell cycle inhibition. Neuropharmacology 86: 9-21, 2014.
19. Chen J, Wang L, Wu C, Hu Q, Gu C, Yan F, Li J, Yan W and Chen G: Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage. J Pineal Res 56: 12-19, 2014.
20. Congdon EE, Wu JW, Myeku N, Figueroa YH, Herman M, Marinec PS, Gestwicki JE, Dickey CA, Yu WH and Duff KE: Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy 8: 609-622, 2012.
21. Humphreys I, Wood RL, Phillips CJ and Macey S: The costs of traumatic brain injury: A literature review. Clinicoecon Outcomes Res 5: 281-287, 2013.
22. Sivanandam TM and Thakur MK: Traumatic brain injury: A risk factor for Alzheimer's disease. Neurosci Biobehav Rev 36: 1376-1381, 2012.
23. Han Z, Du Y, Qi H and Yin W: Post-traumatic malignant glioma in a pregnant woman: Case report and review of the literature. Neurol Med Chir (Tokyo) 53: 630-634, 2013.
24. Kumar A and Loane DJ: Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention. Brain Behav Immun 26: 1191-1201, 2012.
25. Eroglu B, Kimbler DE, Pang J, Choi J, Moskophidis D, Yanasak N, Dhandapani KM and Mivechi NF. Therapeutic inducers of the HSP70/HSP110 protect mice against traumatic brain injury. J Neurochem 130: 626-641, 2014.
26. Lu J, Marmarou A, Choi S, Maas A, Murray G and Steyerberg EW; Impact and Abic Study Group: Mortality from traumatic brain injury. Acta Neurochir Suppl (Wien) 95: 281-285, 2005.
27. Xu FF, Sun S, Ho AS, Lee D, Kiang KM, Zhang XQ, Wang AM, Wu EX, Lui WM, Liu BY and Leung GK: Effects of progesterone vs. dexamethasone on brain oedema and inflammatory responses following experimental brain resection. Brain Inj 28: 1594-1601, 2014.
28. Esen F, Erdem T, Aktan D, Kalayci R, Cakar N, Kaya M and Telci L: Effects of magnesium administration on brain edema and blood-brain barrier breakdown after experimental traumatic brain injury in rats. J Neurosurg Anesthesiol 15: 119-125, 2003.
29. Barzo P, Marmarou A, Fatouros P, Hayasaki K and Corwin F: Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg 87: 900-907, 1997.
30. Lim SW, Wang CC, Wang YH, Chio CC, Niu KC and Kuo JR: Microglial activation induced by traumatic brain injury is suppressed by postinjury treatment with hyperbaric oxygen therapy. J Surg Res 184: 1076-1084, 2013.
31. Parekkadan B, Berdichevsky Y, Irimia D, Leeder A, Yarmush G, Toner M, Levine JB and Yarmush ML: Cell-cell interaction modulates neuroectodermal specification of embryonic stem cells. Neurosci Lett 438: 190-195, 2008.
32. Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WS and Nicoll JA: Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 146: 97-104, 2004.
33. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa G, et al: Inflammation after trauma: Microglial activation and traumatic brain injury. Ann Neurol 70: 374-383, 2011.
34. Duan Y, Haugabook SJ, Sahley CL and Muller KJ: Methylene blue blocks cGMP production and disrupts directed migration of microglia to nerve lesions in the leech CNS. J Neurobiol 57: 183-192, 2003.
35. Dibaj P, Nadrigny F, Steffens H, Scheller A, Hirrlinger J, Schomburg ED, Neusch C and Kirchhoff F: NO mediates microglial response to acute spinal cord injury under ATP control in vivo. Glia 58: 1133-1144, 2010.
36. Gibbs SM and Truman JW: Nitric oxide and cyclic GMP regulate retinal patterning in the optic lobe of Drosophila. Neuron 20: 83-93, 1998.
37. Levine B and Klionsky DJ: Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477, 2004.
38. Diskin T, Tal-Or P, Erlich S, Mizrachy L, Alexandrovich A, Shohami E and Pinkas-Kramarski R: Closed head injury induces upregulation of Beclin 1 at the cortical site of injury. J Neurotrauma 22: 750-762, 2005.
39. Erlich S, Alexandrovich A, Shohami E and Pinkas-Kramarski R: Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26: 86-93, 2007.
40. Wang AM, Morishima Y, Clapp KM, Peng HM, Pratt WB, Gestwicki JE, Osawa Y and Lieberman AP: Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation. J Biol Chem 285: 15714-15723, 2010